Other potential mechanisms of Th17 cell-mediated anti-tumor immunity include T cell plasticity with resultant acquisition by Th17 cells of the dual Th1/Th17 phenotype and production of cytotoxic T cell-activating IFN-γ (108). The gene discussed is IFNG; the disease is neoplasm.